3441-64-3

Usage

Safety Profile

Poison by intraperitoneal, intravenous, and subcutaneous routes. When heated to decomposition it emits very toxic fumes of NOx and HCl.

InChI:InChI=1/C11H15N3O.ClH/c1-9(14-8-11(12)15-13-14)7-10-5-3-2-4-6-10;/h2-6,8-9,13H,7,12H2,1H3;1H

Upstream product

• 10242-52-1 <(α-methylphenethyl)nitrosoamino>acetonitrile 

Downstream Products

• 78915-39-6 N₆-Ethoxycarbonylphenyl-3-phenylisopropylsydnonimine 
• 10242-52-1 <(α-methylphenethyl)nitrosoamino>acetonitrile 
• 87514-44-1 N⁶-(4-methyl-1,3,2-dioxaphosphorinan-2-yl)-3-(α-methylphenethyl)sydnone imine 
• 66404-54-4 3-(1-methyl-2-phenylethyl)-5-[[(4-methoxyphenylamino)carbonyl]amino]-1,2,3-oxadiazolium 
• 57778-26-4 3-[1-methyl-2-(4-nitro-phenyl)-ethyl]-5-(3-methyl-ureido)-[1,2,3]oxadiazolium betaine 
• 57778-19-5 4-bromo-3-(1-methyl-2-phenyl-ethyl)-5-(3-methyl-ureido)-[1,2,3]oxadiazolium betaine 
• 78915-40-9 5-[3-(4-carboxy-phenyl)-ureido]-3-(1-methyl-2-phenyl-ethyl)-[1,2,3]oxadiazolium betaine 
• 69619-33-6 5-(N^α-tert-butoxycarbonyl-tryptophylamino)-3-(1-methyl-2-phenyl-ethyl)-[1,2,3]oxadiazolium betaine 
• 78915-45-4 N₆-Ethoxycarbonylbenzyl-3-phenylisopropylsydnonimine 

Relevant academic research and scientific papers

Synthesis and characterization of hydroxylated mesocarb metabolites for doping control

The synthesis and method of analysis of hydroxylated mesocarb metabolites are described. Six potential hydroxylated mesocarb metabolites were prepared, characterized, and compared with the mesocarb metabolites synthesized enzymatically in vitro using human liver proteins and also compared with metabolites extracted from human urine after oral administration of mesocarb. p-Hydroxymesocarb was the most prevalent metabolite (conjugated and non-conjugated) observed. With respect to doping analysis, synthesis of p-hydroxymesocarb, the main urinary metabolite of mesocarb, and its availability as a reference material is important.